Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,742 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

1,122 of 1,311 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,744 total, page 9 of 35

NOT YET RECRUITING NA

Impact of Patient Choice for Epidural Potency on Maternal Satisfaction

NCT07414407

NOT YET RECRUITING Phase 2

A Trial of Baricitinib in Patients With Cardiac Sarcoidosis

NCT06868381

NOT YET RECRUITING NA

Reset: Enhancing Weight Loss in a Digital Intervention

NCT07032571

NOT YET RECRUITING NA

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise

NCT07226583

NOT YET RECRUITING NA

Vibrotactile Coordinated Reset for Spasticity After Spinal Cord Injury

NCT06290609

COMPLETED NA

IceBath: NOICE vs Nothing

NCT07227142

NOT YET RECRUITING Early Phase 1

Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings

NCT07348172

NOT YET RECRUITING NA

Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D

NCT07501338

NOT YET RECRUITING NA

Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke

NCT05490277

NOT YET RECRUITING Phase 4

Oral Versus Intravenous Acetaminophen in Lumbar Spine Surgery

NCT07203079

COMPLETED NA

Reactions to Social Media Warning Labels Among Teens and Young Adults

NCT07199660

NOT YET RECRUITING Early Phase 1

Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea

NCT07238790

NOT YET RECRUITING NA

Combined Local Anesthetic Blockade and Neuromodulation vs Local Anesthetic Blockade Only for Analgesia After Below-knee Amputation: RCT

NCT06964347

NOT YET RECRUITING NA

The Use of Electrical Stimulation for Determination of Epidural Catheter Placement

NCT06055686

NOT YET RECRUITING NA

Automated Text Message Reminders to Promote Hearing Aid Adoption

NCT07170423

NOT YET RECRUITING

Survey of Anesthesiology Residents' Perceptions of Critical Care Medicine as a Career

NCT05566067

NOT YET RECRUITING NA

Diagnostic Accuracy of Core Stethoscope Auscultation vs. Point of Care Ultrasound in Placement of Endotracheal Tube

NCT04797520

NOT YET RECRUITING NA

Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome

NCT06953661

NOT YET RECRUITING NA

Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism

NCT06058104

NOT YET RECRUITING Phase 2

Amino Acids for Cardiac Surgery Associated AKI

NCT07001098

NOT YET RECRUITING NA

Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients

NCT05558189

NOT YET RECRUITING NA

Evaluation of the Pedal-Controlled Surgistep Platform to Improve Ergonomics

NCT07140835

COMPLETED NA

Short, Animated Storytelling (SAS) for Addiction Stigma Reduction

NCT06705205

NOT YET RECRUITING Phase 1

Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease

NCT06986382

NOT YET RECRUITING NA

Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

NCT06748950

COMPLETED NA

Cooling Solutions for Outdoor Workers

NCT06998667

COMPLETED NA

Microsteps Study-Short, Animated Storytelling Video

NCT06967337

COMPLETED NA

Stronger: Muscle Strengthening for Menopause

NCT06375356

NOT YET RECRUITING

Stanford-Lucidify EEG Delirium Study

NCT06999967

COMPLETED NA

Food Swaps to Improve the Healthfulness and Reduce the Carbon Footprint of Grocery Purchases

NCT06648226

NOT YET RECRUITING NA

SWIR Otoscopy Study

NCT06944795

NOT YET RECRUITING NA

Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population

NCT06029686

NOT YET RECRUITING NA

Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease

NCT05545826

COMPLETED NA

Immersive Mixed Reality Simulation to Evoke Empathy

NCT06351397

NOT YET RECRUITING NA

Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

NCT06028477

NOT YET RECRUITING

Nemaline Myopathy Clinical Research Network (NM-CTRN)

NCT06774703

NOT YET RECRUITING Early Phase 1

Pharmacokinetics of Oral Calcium Carbonate in Parturients

NCT06650930

COMPLETED NA

Diagnostic Reasoning With Customized GPT-4 Model

NCT06911645

COMPLETED NA

ERP Plus Improv Group Therapy for OCD (IMPROVE Study)

NCT06265233

COMPLETED Phase 2

Identification of Nerves Using Fluorescein Sodium

NCT06054178

NOT YET RECRUITING Phase 4

Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention

NCT06682351

COMPLETED NA

Increasing School Meal Participation

NCT06419218

NOT YET RECRUITING NA

Effectiveness Gastric Balloon in Obese Adolescents

NCT04209842

COMPLETED NA

Augmented Reality (AR) Chile

NCT05906173

COMPLETED NA

Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

NCT06364137

COMPLETED NA

Effects of Palmar Cooling on the Human Immune System

NCT07215338

COMPLETED NA

Traditional In-Person Vs. Remote AR Clinical Simulation

NCT06326450

COMPLETED NA

Impact of Vibrating Device Distraction on Mechanical Pain Thresholds Induced by Needle Sham

NCT06271642

COMPLETED

Stanford ICU Delirium PIPRA Study

NCT06519890

COMPLETED

Stanford PIPRA Validation Study in an Elderly Orthopedic Population

NCT06567574

← Previous Page 9 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Stanford University: open-pipeline peers nationwide

Peers matched on 1,744 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Stanford University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Stanford UniversityDuke UniversityUniversity of California, San FranciscoVA Office of Research and DevelopmentPfizerBaylor UniversityCornell UniversityBaylor College of MedicineWake Forest University Health Sciences
Stanford University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Stanford University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,744 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Stanford University page

1,744 registered trials is a research-attention snapshot, not an endorsement of Stanford University or any single study.

  • 264 of Stanford University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autism Spectrum Disorder is the condition Stanford University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Stanford University pipeline card: 1,744 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.